logo

English
                 
 

JULY 17, 2017

Top News in Gastroenterology#4 of 8 

Blood test for early detection of pancreatic cancer headed to clinic

Penn Medicine News

A newly identified biomarker panel could pave the way to earlier detection and better treatment for pancreatic cancer, according to new research from the Perelman School of Medicine at University of Pennsylvania. Currently over 53,000 people in the United States are diagnosed with pancreatic cancer – the fourth leading cause of cancer death – every year. The blood biomarkers, detailed in the journal Science Translational Medicine, correctly detected pancreatic cancer in blood samples from patients at different stages of their disease.

The majority of pancreatic cancer patients are not diagnosed until an advanced stage, beyond the point at which their tumors can be surgically removed.

A team led by Ken Zaret, PhD, director of the Penn Institute for Regenerative Medicine and the Joseph Leidy Professor of Cell and Developmental Biology, and Gloria Petersen, PhD, from the Mayo Clinic, identified a pair of biomarkers that physicians could soon use to discover the disease earlier. “Starting with our cell model that mimics human pancreatic cancer progression, we identified released proteins, then tested and validated a subset of these proteins as potential plasma biomarkers of this cancer,” Zaret said. The authors anticipate that health care providers will use the early–detection biomarkers to test for their presence and levels in blood from pancreatic cancer patients and blood drawn from individuals with a high risk of developing pancreatic cancer, including those who have a first–degree relative with pancreatic cancer, are genetically predisposed to the disease, or who had a sudden onset of diabetes after the age of 50.

“Early detection of cancer has had a critical influence on lessening the impact of many types of cancer, including breast, colon, and cervical cancer. A long standing concern has been that patients with pancreatic cancer are often not diagnosed until it is too late for the best chance at effective treatment,” said Robert Vonderheide, MD, DPhil, director of the Abramson Cancer Center (ACC) at the University of Pennsylvania. “Having a biomarker test for this disease could dramatically alter the outlook for these patients.”

The biomarker panel, enabled by discovery work of first author Jungsun Kim, PhD, a postdoctoral fellow in Zaret’s lab, builds on a first–of–its–kind human–cell model of pancreatic cancer progression the lab described in 2013. They used stem–cell technology to create a cell line from a patient with advanced pancreatic ductal adenocarcinoma. Genetically reprogramming late–stage human cancer cells to a stem–cell state enabled them to force the reprogrammed cells to progress to an early cancerous state, revealing secreted blood biomarkers of early–stage disease along the way. The best candidate biomarker, plasma thrombospondin–2 (THBS2), was screened against 746 cancer and control plasma samples using an inexpensive, commercially available protein–detection assay. The team found that blood levels of THBS2, combined with levels of a known later–stage biomarker called CA19–9, was reliable at detecting the presence of pancreatic cancer in patients.

The team refined the assay with independent investigations of plasma samples from patients with different stages of cancer, from individuals with benign pancreatic disease, and from healthy controls, all obtained from Petersen, who directs the biospecimen resource program for pancreas research at the Mayo Clinic.

“Positive results for THBS2 or CA19–9 concentrations in the blood consistently and correctly identified all stages of the cancer,” Zaret said. “Notably, THBS2 concentrations combined with CA19–9 identified early stages better than any other known method.” The combination panel also improved the ability to distinguish cases of cancer from pancreatitis. The panel will next be validated in a setYou 

No. Subject Date Author Last Update Views
Notice How to write your comments onto a webpage [2] 2016.07.06 운영자 2016.11.20 17768
Notice How to Upload Pictures in webpages 2016.07.06 운영자 2018.10.19 31850
Notice How to use Rich Text Editor [3] 2016.06.28 운영자 2018.10.19 5493
Notice How to Write a Webpage 2016.06.28 운영자 2020.12.23 43427
663 Cognitive Motor Dissociation (CMD) [1] 2023.10.13 운영자 2023.10.13 93
662 Metformin as a Logevity Drug? [2] 2023.05.06 운영자 2023.05.06 81
661 Medical Tourism to Mexico [2] 2022.12.16 온기철*71 2022.12.17 73
660 Fraud in Alzheimer’s disease research [3] 2022.08.30 온기철*71 2022.09.01 106
659 Postmortem Sperm Retrieval Is Turning Dead Men Into Fathers [1] 2022.07.20 운영자 2022.07.20 293
658 COVID19 Another wave in Summer [2] 2022.06.14 온기철*71 2022.06.18 93
657 흰머리, 탈모를 치료할 수있을까? Recent scientific study. [1] 2022.06.04 운영자 2022.06.05 82
656 COVID19 Pandemic is not over yet! [2] 2022.06.01 온기철*71 2022.06.04 70
655 Abortion by Pills [3] 2022.05.07 운영자 2022.05.08 369
654 Ivermectin does nothing to cure Covid [1] 2022.03.31 운영자 2022.03.31 58
653 Brain damage after Covid infection [2] 2022.03.08 운영자 2022.03.08 70
652 Alcohol consumption is bad, no matter how small it is. [1] 2022.03.04 운영자 2022.03.04 75
651 They might have known the source of Covid-19 was Wuhan Lab [1] 2022.01.29 운영자 2022.01.31 55
650 Can You Trust U.S. Medical Care? [2] 2022.01.29 온기철*71 2022.01.30 273
649 If you think that glass of wine is good for you, it's time to reconsider [1] 2022.01.23 운영자 2022.01.23 69
648 서울대 병원 라오스에 국립대학병원 건설 2022.01.02 온기철*71 2022.01.06 1872
647 Alcohol and Cancer Risk; National Cancer Institute [5] 2021.11.09 온기철*71 2021.11.10 160
646 한국 대학병원은 세계에서? [5] 2021.10.01 온기철*71 2021.10.31 119
645 [Medical]Tylenol Use During Pregnancy, Warned [1] 2021.09.24 이한중*65 2021.09.24 21285
644 Israel is talking about the 4th Covid vaccination Now !! [4] 2021.09.13 운영자 2021.09.13 65